Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hemostasis Tests Market Report Overview
The hemostasis tests market size was valued at $594.3 million in 2023. The hemostasis tests market will grow at a CAGR of more than 1% from 2023 to 2033. The increasing prevalence of surgical cases, rise in VTE incidence, and demand for point of care (POC) coagulation testing are driving factors for the growth of the hemostasis testing market. There is demand for POC tests for hemostasis tests due to the time-consuming process of laboratory-based tests that can lead to treatment delays. These diagnostic tests provide rapid results, reduce hospital stays and lead to immediate treatment decisions.
Hemostasis Tests Market Outlook 2023-2033 ($ Billion)
Buy the Full Report for More Insights on the Hemostasis Tests Market Forecast, Download a Free Sample Report
The hemostasis tests market research report explains the market behavior, which will help identify quantitative market trends within in vitro diagnostics therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of hemostasis tests across labs, which will help in identifying untapped market opportunities. The hemostasis tests market model also discusses the detailed impact of COVID-19 on the hemostasis tests market for 2020 and beyond.
Market Size (2023) | $594.3 million |
CAGR (2023-2033) | >1% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Hemostasis Tests Market Dynamics
The prevalence of surgical cases is increasing in many countries and geographical regions. This is expected to lead to higher numbers of prothrombin (PT) tests and activated partial thromboplastin Time (aPTT) tests being used. The incidence of Venous Thromboembolism (VTE) is also increasing worldwide, which is expected to drive sales of D-Dimer tests during the forecast period.
Sales of these devices are also impacted by fluctuations in the number of cases prescribed Vitamin-K antagonists such as warfarin sodium and the average number of annual “Hemostasis tests” performed per case. Usage of warfarin sodium is decreasing in many countries, due to the growing popularity of direct oral anticoagulants such as apixaban, rivaroxaban, edoxaban. This is expected to cause a decline in some North American, European, APAC, and the Middle East, and African markets, primarily for PT tests. Finally, gains in the D-Dimer tests market are expected to bolster the growth of the “Hemostasis Tests” market overall, as D-Dimer tests tend to be more expensive than PT or aPTT tests. With the expanding role of DOACs, clinicians are faced with increasingly complex decisions relating to the appropriate agent, duration of treatment, and use in special populations.
Buy the Full Report for Additional Hemostasis Tests Market Dynamics, Download a Free Sample Report
Hemostasis Tests Market Segments
The key segments in the hemostasis tests market are Activated Partial Thromboplastin Time Laboratory Tests, Activated Partial Thromboplastin Time Point of Care (POC) Tests, D-Dimer Laboratory Tests, D-Dimer Point of Care (POC) Tests, Prothrombin Time Laboratory Tests, and Prothrombin Time Point of Care (POC) Tests. In 2023, the Prothrombin Time Point of Care (POC) Tests segment dominated the market share. The segment is likely to dominate the market during the projected period.
Hemostasis Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment-Wise Insights about the Hemostasis Tests Market Segments, Download a Free Sample Report
Hemostasis Tests Market Segmentation by Regions
The key regions in the hemostasis tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America was the leading regional segment in the hemostasis tests market.
In the US, Canada, and Mexico prothrombin (PT) tests are preferred hemostasis tests to monitor oral anticoagulants (Vitamin-K antagonists) such as warfarin, phenprocoumon, and acenocumarol. These tests also help to identify coagulation abnormalities in the perioperative period.
Hemostasis Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights in the Hemostasis Tests Market, Download A Free Sample Report
Hemostasis tests Market – Competitive Landscape
The key companies in the hemostasis tests market are Abbott Laboratories, Roche Diagnostics International Ltd, Siemens Healthineers AG, Diagnostica Stago SAS, Instrumentation Laboratory Co, and Quidel Corp among others. In 2023, Abbott Laboratories accounted for the highest hemostasis tests market share and value.
Hemostasis Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Hemostasis Tests Market, Download a Free Sample Report
Segments Covered in this Report.
Hemostasis Tests Segment Outlook ($ Million, 2015-2033)
- Activated Partial Thromboplastin Time Laboratory Tests
- Activated Partial Thromboplastin Time Point of Care (POC) Tests
- D-Dimer Laboratory Tests
- D-Dimer Point of Care (POC) Tests
- Prothrombin Time Laboratory Tests
- Prothrombin Time Point of Care (POC) Tests
Hemostasis Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are –
Currently marketed hemostasis tests market and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total hemostasis tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Hemostasis tests market.
- Competitive dynamics insights and trends provided for the hemostasis tests market.
Get an in-depth understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens AG, Diagnostica Stago SAS, Werfen Life Group SAU, Bio-Rad Laboratories Inc, bioMerieux SA, Quidelortho Corp, Danaher Corp, Revvity Inc, and others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is essential for the following stakeholders:
- CMO executives who must have a deep understanding of the hemostasis tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on hemostasis tests.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving hemostasis tests.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the hemostasis tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific hemostasis tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
F. Hoffmann-La Roche Ltd
Siemens AG
Diagnostica Stago SAS
Werfen Life Group SAU
Bio-Rad Laboratories Inc
bioMerieux SA
Quidelortho Corp
Danaher Corp
Revvity Inc
Frequently asked questions
-
What was the hemostasis tests market size in 2023?
The hemostasis tests market size was $594.3 million in 2023.
-
What will the CAGR of the hemostasis tests market be during 2023-2033?
The hemostasis tests will grow at a CAGR of more than 1% during 2023-2033.
-
Which was the leading segment in the hemostasis tests market in 2023?
Prothrombin Time Point of Care (POC) tests segment was leading the hemostasis tests market in 2023.
-
Which region held the largest share of the hemostasis tests market in 2023?
North America was the largest regional market for hemostasis tests in 2023.
-
Which are the leading players in the hemostasis tests market?
The key companies in the hemostasis tests market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens AG, Diagnostica Stago SAS, Werfen Life Group SAU, Bio-Rad Laboratories Inc, bioMerieux SA, Quidelortho Corp, Danaher Corp, Revvity Inc, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.